HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer.

AbstractBACKGROUND:
This study analyzed the clinical results of palliative radiotherapy for bleeding control in patients with unresectable advanced gastric cancer.
METHODS:
We retrospectively reviewed the medical records of patients who met the following inclusion criteria between January 2002 and June 2018: histologically proven gastric cancer, gastric tumor bleeding confirmed by upper gastrointestinal endoscopy, and palliative radiotherapy performed for hemostasis. The median radiotherapy dose was 30 Gy, with a daily dose ranging from 1.8 to 3 Gy.
RESULTS:
Sixty-one patients were included in this analysis. The study population was predominantly male (72.1%), with a median age of 62 years (range: 32-92). The median baseline hemoglobin level was 7.1 g/dL, and the most common presenting symptom of gastric tumor bleeding was melena (85.2%). Bleeding control was achieved in 54 (88.5%) patients. The median levels of hemoglobin at 1, 2, and 3 months after completion of radiotherapy were 10.1 g/dL, 10.2 g/dL, and 10.4 g/dL, respectively; these values were significantly different from that before radiotherapy (7.1 g/dL; p < 0.001). The median overall survival was 4.8 months. Among the 54 patients who achieved bleeding control after radiotherapy, 19 (35.2%) experienced re-bleeding during the follow-up period. The median time to re-bleeding was 6.0 months. Multivariate analysis demonstrated that a higher radiation dose (p = 0.007) and additional chemotherapy after radiotherapy (p = 0.004) were significant factors for prolonging the time to re-bleeding.
CONCLUSIONS:
Tumor bleeding was adequately controlled by radiotherapy in patients with unresectable advanced gastric cancer.
AuthorsJesang Yu, Jinhong Jung, Sook Ryun Park, Min-Hee Ryu, Jin-Hong Park, Jong Hoon Kim, Sang Min Yoon
JournalBMC cancer (BMC Cancer) Vol. 21 Issue 1 Pg. 413 (Apr 15 2021) ISSN: 1471-2407 [Electronic] England
PMID33858353 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Female
  • Gastrointestinal Hemorrhage (diagnosis, etiology, prevention & control)
  • Hemostasis
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Palliative Care (methods)
  • Prognosis
  • Radiotherapy, Adjuvant (adverse effects, methods)
  • Retrospective Studies
  • Stomach Neoplasms (blood, complications, pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: